Cadherin-13 in primary and blast crisis chronic myeloid leukaemia: declining expression and negative correlation with the BCR/ABL fusion gene
暂无分享,去创建一个
P. Xie | H. Mu | H.-J. Mu | P. Xie | Y.-F. Shen | Y.-Q. Jiang | Y.-J. Zeng | Y.-F. Shen | Y-Q Jiang | Y.-J. Zeng | YJ Zeng | Y-Q Jiang
[1] M. Greaves,et al. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.
[2] B. Ranscht,et al. Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium- dependent, homophilic cell adhesion , 1992, The Journal of cell biology.
[3] C. Verfaillie,et al. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. , 1994, The Journal of clinical investigation.
[4] Sam W. Lee. H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer , 1996, Nature Medicine.
[5] R. Bhatia,et al. The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia. , 1998, Leukemia & lymphoma.
[6] R. Bhatia,et al. Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. , 1998, Blood.
[7] R. Bhatia,et al. Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. , 1999, Experimental hematology.
[8] M. Sato,et al. Chromosome band 16q24 is frequently deleted in human gastric cancer , 1999, British Journal of Cancer.
[9] L. Hartmann,et al. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. , 1999, International journal of oncology.
[10] E. Andreu,et al. Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL , 2000, The Journal of experimental medicine.
[11] V. Moreno,et al. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. , 2000, Haematologica.
[12] K. Akashi,et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. , 2001, Blood.
[13] B. Angst,et al. COMMENTARY The cadherin superfamily: diversity in form and function , 2022 .
[14] R. Perez-soler,et al. Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] J. Bourhis,et al. BCR-ABL down-regulates the DNA repair protein DNA-PKcs. , 2001, Blood.
[16] J. Minna,et al. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. , 2001, Cancer research.
[17] Matthew B. Wilson,et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.
[18] S. Minucci,et al. Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.
[19] S. Toyooka,et al. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. , 2002, Cancer research.
[20] M. Caligiuri,et al. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. , 2002, Nature genetics.
[21] H. Iwasaki,et al. Critical role for Gab2 in transformation by BCR/ABL. , 2002, Cancer cell.
[22] P. Paschka,et al. Imatinib restores expression of CD62L in BCR‐ABL‐positive cells , 2003, Journal of leukocyte biology.
[23] T. Ueda,et al. Expression of the antiapoptotic gene survivin in chronic myeloid leukemia. , 2003, Anticancer Research.
[24] A. Grañena,et al. Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Eric Deutsch,et al. Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. , 2003, Blood.
[26] D. Gutmann,et al. T-Cadherin-Mediated Cell Growth Regulation Involves G2 Phase Arrest and Requires p21CIP1/WAF1 Expression , 2003, Molecular and Cellular Biology.
[27] S. Minucci,et al. Epigenetic gene silencing in acute promyelocytic leukemia. , 2004, Biochemical pharmacology.
[28] P. Pelicci,et al. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo , 2005, Oncogene.
[29] J. Melo,et al. Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia , 2005, Oncogene.
[30] C. Bueso-Ramos,et al. New insights into the pathobiology and treatment of chronic myelogenous leukemia. , 2007, Annals of diagnostic pathology.
[31] A. Utani,et al. T‐cadherin enhances cell–matrix adhesiveness by regulating β1 integrin trafficking in cutaneous squamous carcinoma cells , 2007, Genes to cells : devoted to molecular & cellular mechanisms.
[32] Z. Modrušan,et al. Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. , 2007, Differentiation; research in biological diversity.